Dennis L. Johnson
Known title: DirectorCIK: 0001572624
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Lowers Idacorp Price Target to $149. Barclays maintained its overweight rating on Idacorp but reduced its price target to $149. This action occurred alongside reports of rising customer demand and the company's upcoming third-quarter earnings release. The stock currently trades near the upper end of its 52-week range, with an average analyst target of $153.89.
Transaction History
| FIBK | ▲ Buy | Grant | 2,247 | $0 | 6/1/2026 | View on chart |
| IDA | ▲ Buy | Grant | 1,007 | $0 | 3/1/2026 | View on chart |
| FIBK | ▲ Buy | Grant | 2,946 | $0 | 6/1/2025 | View on chart |
| IDA | ▲ Buy | Grant | 1,187 | $0 | 3/1/2025 | View on chart |
| FIBK | ▲ Buy | Grant | 3,014 | $0 | 6/1/2024 | View on chart |
| IDA | ▲ Buy | Grant | 1,588 | $0 | 3/1/2024 | View on chart |
| FIBK | ▲ Buy | Grant | 3,401 | $0 | 6/1/2023 | View on chart |
| IDA | ▲ Buy | Grant | 1,160 | $0 | 3/1/2023 | View on chart |
| IDA | ▼ Sell | Open Market | 1,365 | $149K | 12/1/2022 | View on chart |
| FIBK | ▲ Buy | Grant | 1,576 | $60K | 6/1/2022 | View on chart |
| IDA | ▲ Buy | Grant | 1,154 | $0 | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
FIBK Earnings Due Next Week Amid Valuation Debate
First Interstate BancSystem is set to report earnings next week, with analysts anticipating growth. Recent commentary suggests the stock may be undervalued based on excess returns, though questions remain if the current recovery is already priced in. The company trades near its 52-week low, with a dividend yield of 7.76% and an average analyst target of $37.00.
FIBK Earnings Due Next Week Amid Valuation Debate. First Interstate BancSystem is set to report earnings next week, with analysts anticipating growth. Recent commentary suggests the stock may be undervalued based on excess returns, though questions remain if the current recovery is already priced in. The company trades near its 52-week low, with a dividend yield of 7.76% and an average analyst target of $37.00.